Curepro Parenterals Limited

Produces injectable pharmaceutical drugs, including oncology and anti-infective products, for Aurobindo Pharma Limited.

2013 | Hyderabad, Telangana (India) | Merged
Last Updated:

Curepro Parenterals Profile

Key Indicators

  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 13.31 Cr
  • Company Age 11 Year, 10 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth %
  • Profit Growth -28752.27%
  • Ebitda -62.79%
  • Net Worth -0.64%
  • Total Assets 13.13%

About Curepro Parenterals

Curepro Parenterals Limited (CPL) is Amalgamated company established on 19 Apr 2013 with its office registered at Hyderabad, Telangana, India and has been running since 11 Year, 10 Months with a paid up capital of 13.31 Cr. According to MCA records, 4 Directors and 2 Signatories are linked to this company as of 16 Jan 2025.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232TG2013PLC087101

  • Company No.

    087101

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    19 Apr 2013

  • Date of AGM

    24 Aug 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Curepro Parenterals?

Executive Team (2)

NameDesignationAppointment DateStatus
Srinivasarao Devathi CFO21-May-2020Current
Venkat Kupireddy Country flag representing In Company Secretary10-Jun-2019Current

Board Members (4)

NameDesignationAppointment DateStatus
Madan Mettu Country flag representing In Director 21-Aug-2013Current
Sivakumaran Meenakshisunderam Country flag representing In Director 25-Jun-2015Current
Sarath Penaka Country flag representing In Director 12-Sep-2013Current
Bhanu Chavali Country flag representing In Whole-Time Director 27-May-2019Current

Financial Performance of Curepro Parenterals.

Curepro Parenterals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28752.27% decrease in profit. The company's net worth dipped by a decrease of 0.64%.

Curepro Parenterals revenue growth over time
Curepro Parenterals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
13.13%
Profit or Loss
-28752.27%
Net Worth
-0.64%
EBITDA
-62.79%

What is the Ownership and Shareholding Structure of Curepro Parenterals?

In 2019, Curepro Parenterals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Curepro Parenterals?

Unlock and access historical data on people associated with Curepro Parenterals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Curepro Parenterals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curepro Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curepro Parenterals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Curepro Parenterals

Recent activity within the organization

  • Annual General Meeting

    Curepro Parenterals Limited last Annual general meeting of members was held on 24 Aug 2020 as per latest MCA records.

  • Director Appointment

    Srinivasarao Devathi was appointed as a Cfo was appointed as a Cfo on 21 May 2020 & has been associated with this company since 4 years 9 months .

  • Balance Sheet

    Curepro Parenterals Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.

  • Director Appointment

    Venkat Reddy Kupireddy was appointed as a Company Secretary was appointed as a Company Secretary on 10 Jun 2019 & has been associated with this company since 5 years 8 months .

  • Director Appointment

    Bhanu Murthy Chavali was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 27 May 2019 & has been associated with this company since 5 years 9 months .

  • Director Appointment

    Sivakumaran Meenakshisunderam was appointed as a Director was appointed as a Director on 25 Jun 2015 & has been associated with this company since 9 years 8 months .

Frequently asked questions

  • What is the Incorporation or founding date of Curepro Parenterals Limited?

    Curepro Parenterals Limited was incorporated on 19 Apr 2013.

  • What is authorized share capital and paid-up capital of Curepro Parenterals Limited?

    The authorized share capital of Curepro Parenterals Limited is ₹ 20.00 Cr and paid-up capital is ₹ 13.31 Cr.

  • Who are the current board members & directors of Curepro Parenterals Limited?

    Currently 6 directors are associated with Curepro Parenterals Limited.

    • Madan Mohan Reddy Mettu
    • Sivakumaran Meenakshisunderam
    • Sarath Chandra Reddy Penaka
    • Bhanu Murthy Chavali
    • Srinivasarao Devathi
    • Venkat Reddy Kupireddy

  • What is the registered address of Curepro Parenterals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Curepro Parenterals Limited is Plot No.2, Maitrivihar Ameerpet India, Hyderabad, Telangana, 500038.

  • What is the corporate identification number (CIN) and company number of Curepro Parenterals Limited?

    The corporate identification number (CIN) of Curepro Parenterals Limited is U24232TG2013PLC087101 and the company number is 087101 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Curepro Parenterals Limited?

    The Official website of Curepro Parenterals Limited is https://www.aurobindo.com

  • What change has been observed in the net worth of Curepro Parenterals Limited, and by what percentage?

    The financial reports for the fiscal year 2019 indicates that The net worth of Curepro Parenterals Limited has experienced an downturn of -0.64%.

  • When was the last Balance Sheet of Curepro Parenterals Limited filed with the ROC?

    The most recent Balance Sheet for Curepro Parenterals Limited was filed with the ROC on 31 Mar 2020.

People also Viewed

Similar Companies Based on Drug Formulation & Development